Do quality-of-life randomized clinical trials support clinicians in their decision-making?

Comment

Fabio Efficace et al. J Clin Oncol. 2002.

. 2002 Oct 1;20(19):4126-7; author reply 4127.

doi: 10.1200/JCO.2002.99.117.

No abstract available

Comment in

Quality-of-life meta-analysis: why treat it differently?
Sloan JA. Sloan JA. J Clin Oncol. 2003 Apr 1;21(7):1422. doi: 10.1200/JCO.2003.99.037. J Clin Oncol. 2003. PMID: 12663740 No abstract available.
Surrogate outcomes in quality-of-life research: where will we end up?
Tassinari D, Panzini I, Sartori S, Ravaioli A. Tassinari D, et al. J Clin Oncol. 2003 May 1;21(9):1894-5; author reply 1895. doi: 10.1200/JCO.2003.99.244. J Clin Oncol. 2003. PMID: 12721275 No abstract available.

Beyond the development of quality-of-life instruments: where do we go from here?
Levine MN, Ganz PA. Levine MN, et al. J Clin Oncol. 2002 May 1;20(9):2215-6. doi: 10.1200/JCO.2002.20.9.2215. J Clin Oncol. 2002. PMID: 11980989 No abstract available.